Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
108.89
-0.22 (-0.20%)
Apr 15, 2024, 4:00 PM EDT - Market closed
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 125.2, with a low estimate of 107 and a high estimate of 141. The average target predicts an increase of 14.98% from the current stock price of 108.89.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ABT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 6 | 4 | 4 | 3 |
| Buy | 10 | 7 | 6 | 5 | 5 | 5 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 16 | 15 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $120 → $125 | Buy | Maintains | $120 → $125 | +14.79% | Apr 4, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $126 → $128 | Strong Buy | Maintains | $126 → $128 | +17.55% | Apr 3, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $128 | Buy | Reiterates | $128 | +17.55% | Feb 14, 2024 |
| Barclays | Barclays | Buy Maintains $133 → $141 | Buy | Maintains | $133 → $141 | +29.49% | Jan 26, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $123 → $126 | Strong Buy | Maintains | $123 → $126 | +15.71% | Jan 25, 2024 |
Financial Forecast
Revenue This Year
42.43B
from 40.11B
Increased by 5.78%
Revenue Next Year
45.46B
from 42.43B
Increased by 7.14%
EPS This Year
4.64
from 3.26
Increased by 42.36%
EPS Next Year
5.14
from 4.64
Increased by 10.86%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 44.7B | 48.0B | 51.9B | 54.2B | 58.2B |
| Avg | 42.4B | 45.5B | 48.7B | 50.6B | 56.0B |
| Low | 40.9B | 43.3B | 45.6B | 47.4B | 54.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.3% | 13.2% | 14.2% | 11.3% | 15.0% |
| Avg | 5.8% | 7.1% | 7.1% | 4.0% | 10.6% |
| Low | 2.0% | 2.1% | 0.3% | -2.6% | 7.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.94 | 5.63 | 6.32 | 6.87 | 7.68 |
| Avg | 4.64 | 5.14 | 5.73 | 6.10 | 7.38 |
| Low | 3.92 | 4.30 | 5.17 | 5.42 | 7.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 51.4% | 21.3% | 22.9% | 19.9% | 25.8% |
| Avg | 42.4% | 10.9% | 11.3% | 6.5% | 21.0% |
| Low | 20.2% | -7.3% | 0.6% | -5.4% | 17.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.